In a randomized, double-blind, active-controlled study of Drug X for the treatment of anemia in subjects with non-myeloid malignancy receiving multi-cycle chemotherapy, Quintiles carried out a feasibility study and chose the sites where the patients would be easy to find. Quintiles Study Site Coordinators helped investigators prescreen the patients so that as soon as the Site Initiation Visit took place the patients were ready to be randomized. Learn more by reading the case study.